DIGITAL ADVANTAGE FOR LIFE SCIENCES
A modern and open technology platform for life sciences
Agile and safe clinical trials are key to faster drug development
The need to synthesize data from different sources increases the risk of regulatory non-compliance for pharma companies. As a result, they face an exponential increase in clinical research and development costs, sub-optimal clinical trial execution, and delays in launching new, approved drugs. TCS ADD enables digital ecosystems, simplifies data complexity, and drives innovation in clinical trials to bring drugs to market faster.
Quicker decision-making with real-time access to data
Faster drug registration with adaptive trial design
Improved data quality with advanced analytics
Unified platform for sites, patients, and regulators
TCS helped Roche roll out an eConsent solution
A ready-to-use, interoperable, metadata-driven AI solution that automates study design, enables robust governance, and rapidly generates submission-ready datasets.
An integrated solution on the cloud catering to all data management needs of pharma.
An analytics-based platform that leverages AI and ML to enable quicker decisions, faster study start-ups, and targeted interventions.
A decentralized platform that digitally harmonizes clinical trial processes for accelerated time-to-market for drugs.
A cognitive solution that integrates data from diverse sources and enables automated intake, processing, analysis, and reporting of a high volume of safety cases.
A solution that leverages modern technologies to automate regulatory processes and enable faster, compliant drug registration.
TCS ADD wins at 2021 India Pharma Awards
TCS ADD Safety wins 2020/21 Awards.AI for using AI to reimagine pharmacovigilance
TCS wins Best Patient-facing Technology Initiative at the Citeline Awards 2020
TCS Recognized as a Leader in IDC MarketScape for Life Science R&D Decentralized Clinical